UCLA investigators show that using advanced MRI imaging and targeted focal therapy can help many men with low- to intermediate-risk prostate cancer safely stay on active surveillance long-term, helping avoid follow-up biopsies and delay — or even avoid — invasive treatments like surgery or radiation.  

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings, published in Nature Cancer, may help improve future ways to deliver this cellular immunotherapy for metastatic non-small cell lung cancer.

Cleft lip and cleft palate, collectively referred to as orofacial clefts, are among the most common craniofacial birth defects in the United States. A new study led by ADA Forsyth adjunct faculty Dr. Eric Kang Ting suggests a cutting-edge therapeutic approach using fibromodulin, a molecule that regulates myofibroblasts at the site of tissue closure, may mitigate or even prevent excessive scarring following surgical orofacial cleft repair, significantly advancing the field of wound healing and regeneration.